Transcript BioSense Sentinel Alert Experience: New Jersey, November, 2004

New Jersey Experience and
Protocol Development
Teresa Hamby
Infectious & Zoonotic Disease Program
New Jersey Department of Health & Senior
Services
Outline
 Introduction
 Overview
of NJ Surveillance
 Protocol Development
 Conclusions
2
NJ Surveillance - Overview
 NJ Public Health Partners
o NJDHSS
o Local Information Network Communications
System (LINCS)



NJ’s HAN
22 jurisdictions statewide
Regional epidemiologists in each LINCS agency
o Local Health Departments
 Total 114
o Hospitals
 Approximately 80 acute care facilities
3
NJ Surveillance - Components
 Emergency
Department (ED)
Surveillance
o Daily analysis of ED visits and admissions
o Enhanced during periods of heightened
threat status
 Hospital Divert Status
o Housed in NJDHSS
o Website review
o Relate to ED volume
4
NJ Surveillance - Components
 Communicable
Disease Reporting
and Surveillance System (CDRSS)
o Weekly reporting
 Over-The-Counter
Drug Sales
o Daily RODS website review
o FTP download and analysis
 BioSense
o Daily review
5
BioSense Experiences
 “Initiation
by Smallpox”
o FIRST SIA follow up investigation by state
or local PH
o Approximately three weeks after SIAs
implemented
o Diagnosis related to vaccination reaction in
military personnel
6
Experiences
 Additional
alerts
o Miscodes
 Plague
 Crimean hemorrhagic fever
o Vaccination-related
 Yellow fever
 Because
of experiences = need for
guidance in response at both state and
local levels
7
Protocol Development
 Need
for…
o Role-specific guidance
 NJDHSS surveillance staff
 NJDHSS epidemiology staff
 Regional epidemiologists / investigators
o Level of response?
o Clear instructions for investigation and
follow up
8
Protocol Development
 Existing
models to draw from…
o Republican Convention, NYC 2004
o Presidential Election 2004
o Smallpox Vaccination Program
9
Protocol Elements
 Description
of BioSense system and
SIAs
 Instructions by staff role
o Assessment of true “threat”?
o Investigation and follow up requirements
 Closure
of event
10
Update

Current status
o Review and comment by Medical and Program
Directors
o LINCS epidemiologists developing similar protocol
for local use

Next steps
o Feedback from epidemiology staff at NJDHSS
o Input from LINCS epidemiologists
o Final approval by all partners
11
Conclusions
 BioSense
is one component of NJ’s
surveillance activities
 Specific SIA experiences revealed need
for protocol development at state and
local levels
 Protocol development is an ongoing
activity
o Additional experiences help in fine-tuning
response expectations
12
Thank you!
Contacts:
Teresa Hamby
[email protected]
Stella Tsai
[email protected]
Infectious & Zoonotic Disease Program
(609) 588-7500
13